M&G Plc position in DGX
QUEST DIAGNOSTICS INC · Health Care
M&G Plc reported holding 770,102 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$179.4M, representing 0.92% of its reported portfolio and ranking #33 among its reported holdings. M&G Plc has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR
How M&G Plc's DGX position evolved
M&G Plc first disclosed a stake in DGX in Q1 2024 at 349,116 shares (US$46.4M). The position peaked in Q3 2025 at 1,090,377 shares, worth US$208.3M. Across 11 filings, M&G Plc increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 770,102 shares valued at US$179.4M — a reduction of -25,548 shares quarter over quarter.. Notable position changes include a 257% increase in Q2 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 349.12K | $46.43M | New |
| Q2 2024 | 334.37K | $45.81M | Reduce |
| Q3 2024 | 332.00K | $51.46M | Reduce |
| Q4 2024 | 320.92K | $48.46M | Reduce |
| Q1 2025 | 300.90K | $50.85M | Reduce |
| Q2 2025 | 1.07M | $193.09M | Add |
| Q3 2025 | 1.09M | $208.26M | Add |
| Q4 2025 | 945.05K | $164.44M | Reduce |
| Q1 2026 | 805.34K | $157.85M | Reduce |
| Q2 2026 | 795.65K | $168.68M | Reduce |
| Q3 2026 | 770.10K | $179.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 30 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.74M sh · $1.00B · Q2 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.89M sh · $400.21M · Q2 2026
- DAVIS SELECTED ADVISERS 1.56M sh · $329.78M · Q2 2026
FAQ
How long has M&G Plc held DGX?
M&G Plc has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is M&G Plc's current position in DGX?
As of Q3 2026, M&G Plc holds 770.10K shares of DGX (QUEST DIAGNOSTICS INC), valued at $179.43M, representing 0.92% of its reported portfolio and ranking #33.
Has M&G Plc been buying or selling DGX?
In the latest 13F filing (Q3 2026), M&G Plc reduced its position in DGX. The position peaked in Q3 2025 at 1.09M shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.